[1]
K. Saini and S. Sharma, “Use of Tyrosine Kinase Inhibitors for treating Type 2 Diabetes Mellitus: An appraisal”, Chem Biol Lett, vol. 9, no. 3, p. 320, Mar. 2022, Accessed: Jul. 22, 2024. [Online]. Available: https://pubs.thesciencein.org/journal/index.php/cbl/article/view/320